The VAC4EU secretariat is organising this short initial capacity assessment as partner of the ACCESS(vACcine Covid-19 monitoring readinESS) project.
The aim of the ACCESS project is to ensure that a European infrastructure will be in place to effectively monitor COVID-19 vaccines in the real world after their authorisation in the European Union. ACCESS partners prepare protocols for vaccine coverage, effectiveness and safety, generate background rates in 7 EU countries and assess the capacity of organisations throughout Europe to participate in studies. The project is funded by the European Medicines Agency (EMA) and the infrastructure must be delivered in December 2020. The funding of the actual implementation of the studies is not secured and could be provided by various sources (e.g. EC, EMA, ECDC, vaccine manufacturers) under the VAC4EU governance
The objective of this survey is to identify the interest of research, public health and regulatory organisations to participate into the ACCESS project and become partners of the studies on Covid-19 vaccines that may be performed. The survey includes 8 questions and can be answered in few minutes. If you are interested, we will contact you for a more detailed assessment based on specific protocol requirements in October 2020. Your contact details will be kept confidentially by the VAC4EU secretariat (secretariat@vac4eu.org)

Question Title

* 1. What are your organisational contact details? (please use English names) 

Question Title

* 2. How would you classify your organisation ? (multiple possibilities)

Question Title

* 3. What type of vaccine related studies do you/your group conduct? (multiple possibilities)

Question Title

* 4. Is your group already engaged in planning of national/local studies for monitoring of COVID-19 vaccines? please explain type of studies you plan to do (effectiveness, safety, coverage....) 

Question Title

* 5. Would your group be interested and able to potentially participate in providing access to data /collect data for any of the following type of EU collaborative studies? Please tick for which type of studies you may in principle be able to collect /provide access to data. For each type of study you indicate we will contact you for a follow-up survey/discussion. For more details see VAC4EU website on COVID-19 vaccine monitoring

Question Title

* 6. If you are interested to participate in studies on Covid-19 vaccines, do you have any restriction in case of studies funded by one or several vaccine manufacturers, using the ADVANCE or ENCePP Codes of Conduct and the VAC4EU governance?

Question Title

* 7. Do you agree that we contact you again to further explore possibilities and details in your organisation or country?

Question Title

* 8. Would you like to inform us of other persons we could contact regarding participation in post-licensure Covid-19 studies in your organisation or country? If so, could you provide us with the email address ? 

0 of 8 answered
 

T